37 results about "Mental symptoms" patented technology

The invention relates to an E-mental symptom fast screening and self-checking system for assisting diagnosis and treatment. The system comprises an initial interface, a scale selecting interface, a scale assessing interface and a detecting result interface. The scale selecting interface comprises four selectable scales including a QIDS-SR 16, an HCL-32, an MDQ and a PHQ-9, and the four scales are self-rating depression scales. The detecting result interface comprises grades, condition description, clinic prompt and an instruction. By means of the testing result, a patient can be guided to pertinently see a doctor, and the doctor can be assisted to carry out the diagnosis and treatment. The system can serve as a screening tool for bipolar disorder and other diseases and can also serve as a tool for monitoring the illness. The tablet personal computer technology serves as the basis, the system is simple in structure, and operation is easy and convenient due to the fact that input is achieved through a touch screen and a computer keyboard.

An evaluator includes a heart rate variability analyzer A having a heart rate measuring instrument, a heartbeat interval measuring instrument, a frequency analyzer, a sympathetic/parasympathetic nervous system index analyzer, and a psychiatric symptom/psychotic disorder onset risk calculator, and a random number generation analyzer having a random number input unit, a random number score calculation unit, and a display unit. Frequency analysis of a heart rate measurement and a heartbeat interval measurement of a subject is performed to determine a high-frequency index, a low-frequency index and a ratio therebetween,

Pharmaceutical compositions containing the therapeutically active ingredients of azelastine or a pharmaceutically acceptable salt of azelastine and alprazolam are disclosed. Methods of using the pharmaceutical compositions for treating patients with Alzheimer's disease for symptoms of depression, anxiety, agitation, delusions, hallucination, irritability and sleeping disorder, are also disclosed.

The present invention relates to a method of treating psychiatric symptoms in a subject having a NMDA receptor and a NE receptor which includes administering d-methadone, d-methadol, d-alpha-acetylmethadol, l-alpha-acetylmethadol, d-alpha-normethadol, l-alpha-normethadol, pharmaceutically acceptable salts thereof, or mixtures thereof, to the subject under conditions effective for the substance to bind to the NMDA receptor and NE receptor of the subject.

The invention relates to an oral solid medicine composition for nervous system diseases. The composition is a tablet and comprises an active component, lactose anhydrous, a disintegrating agent and an adhesive. The medicine composition can be used for a cerebrovascular disease, used for improving brain metabolism and mental symptoms, activating respiratory activity of brain mitochondria, improving brain energy metabolism of brain ischemia, increasing a utilization ratio of glucose in a brain, allowing adenosine triphosphate produced in the brain to be increased, preventing brain mitochondrion from generating peroxidized lipin, and inhibiting a membrane obstruction due to lipid peroxidation of a brain mitochondrial membrane, used for brain function injures caused by the chronic cerebrovascular disease, brain trauma and the like, and used for improving mental and behavioral disorders such as a subjective symptom, a language disorder, anxiety, depression, hypomnesia and brain power declining, promoting brain power, activating a brain mitochondrion function, improving the brain energy metabolism and a brain function, improving emotion depression, low consciousness, an affective disorder, a language disorder and the like that are caused by a cerebral infarction sequela, a cerebral hemorrhage sequela and cerebral arteriosclerosis, improving brain metabolism, and protecting cranial neural cells.

The present invention discloses a kit for assisting in determining the degree of the risk of the emergence of psychotic symptoms of a methamphetamine user. The kit comprises a parameter acquisition scale and a readable carrier; and the parameter acquisition scale comprises scales for acquiring various parameters involved in the readable carrier; the readable carrier records the content of a formula I that y=0.149xseverity+0.018xCTQ+0.079xADHD 0.034xSSS, wherein xseverity indicates the scores of the severity of addiction to methamphetamine, xCTQ indicates the total scores of childhood trauma experience, xADHD indicates the total scores of the ADHD (attention deficit hyperactivity disorder) during primary school, xSSS indicates the total scores of the social support degree of a subject, andy indicates the risk of the emergence of the psychotic symptoms of the subject, wherein the subject is 18 to 60 years old. According to the kit of the invention, if the value of y is 0, it is indicated that the mental health of the subject is normal; if the value of y ranges from 0 to 1, it is indicated that the greater the value of y is, the greater the risk of the emergence of the psychotic symptoms of the subject is. The kit of the invention is easy to use. With the kit adopted, a scientific basis can be provided for a relationship between addiction to medicines and mental illness, and early warning can be performed for patients addicted to medicines.

The invention discloses application of a rat model with depression related to a chronic pain in researching on an action mechanism and targets of an antidepressant on pain. According to the model, lumbar 5 spinal nerve of a rat is ligated to cause distinct mechanical hyperalgesia and abnormal pain, accomplished with depression symptom. Then the ligation is released, and the abnormal pain behaviors of animals gradually disappear, but the psychiatric symptoms continue to exist. The depression model prepared by the invention can simulate a clinical phenomenon which is that pains disappear but emotional disorders still exist after treatment for the chronic pain patients, and then the action mechanism and the targets of the antidepressant on pain is understood from the source.

The invention relates to a hydroxydecyl quinone derivative for treating or preventing nerve diseases. Specifically, the invention relates to the hydroxydecyl quinone derivative as shown in formula I, a pharmaceutical composition containing the compound as shown in the formula I, and a preparation method and uses of the hydroxydecyl quinone derivative in preparation of medicaments for cerebrovascular diseases. The compound disclosed by the invention can effectively treat or prevent the diseases or disease symptoms: the cerebrovascular diseases, improve cerebral metabolism and improve mental symptoms, activate brain mitochondrial respiratory activity, improve cerebral energy metabolism of cerebral ischemia, improve the utilization rate of cerebral glucose, increase the production of cerebral triphosadenine, inhibit the generation of lipid hydroperoxide from brain mitochondria and inhibit the membrane disorder caused by overoxidation action of the brain mitochondrial membrane lipid, reduce impaired brain functions caused by chronic cerebrovascular diseases, cerebral trauma and the like, improve subjective symptoms, language, anxiety, depression, hypomnesia, intelligence decrease and other mental and behavioral disorders, promote the intelligence, and activate brain mitochondrial functions, improve the cerebral energy metabolism and improve brain functions.

The invention relates to a medicament for treating sequela of cerebral apoplexy and senile dementia. Natural Chinese herbal medicines are reasonably compatible and scientifically processed, in order to nourish kidney and replenish essence, nourish true potential and accept convergence; strengthen spleen and benefit vital qi, obey properties and reach yang qi, and extinguish wind and relax vein; descend turbid and discharge phlegm and blood stasis, induce resuscitation and restore consciousness, and nourish heart and quiet spirit. Yin and yang in equilibrium, and neutral five zang viscera are realized. The medicament can be applied to nerve and mental diseases as well as psychological barrier diseases. The product has good control effects for hemiplegia, paraplegia, facial paralysis, language barrier, dysphagia, cognitive disorder, urinary and fecal incontinence, dull expression, intellectual deterioration, memory loss and miscalculation as well as bad mental symptoms, depression, headache, insomnia, epilepsy, and the like, and the treatment effective rate reaches 90% or above. The medicament is processed, lipophilic properties are increased, active ingredients can easily permeate ablood cerebral barrier formed by a lipoid bilayer, targeted treatment effects are performed, effective components can be rapidly released, biological effects are performed, and curative effects are substantially improved.

The invention relates to the technical field of tea processing, in particular to orange-scented wood green tea and a processing method thereof. The invention provides the orange-scented wood green teaand the processing method thereof; the orange-scented wood green tea is obtained by mixing tea leaves with orange-scented wood according to a specific proportion, then spreading, carrying out fixation, rolling, making into strips, and then drying together; the tea leaves are enabled to fully absorb the beneficial components and fragrance in the orange-scented wood, and the fragrance of the orange-scented wood is blended with the aroma of the tea leaves, so that the orange-scented wood is enabled to give full play to the effects of calming and eliminating depression mood as well as functions of regulation and appeasement of the parasympathetic nervous system, the effects of relaxing the mood, invigorating the mind, reducing insomnia, anxiety and stress are further achieved, the mental symptoms such as psychological disorders and anxiety, depression and mild fatigue which are caused by more caffeine in the green tea are eliminated, the bitterness of the green tea is reduced, and tea soup becomes tastier and more refreshing; the orange-scented wood green tea, which is rich in nutrition, fresh and smooth, and does not cause the symptoms such as the psychological disorders and the anxiety, is finally obtained.

The invention discloses application of an EPA and DHA blending agent in preparing a preparation for preventing and/or treating anxiety and ahedonia caused or deteriorated by nerve inflammation, wherein the mass ratio of EPA to DHA is 1 to (1.5-4). The EPA and DHA blending agent with the mass ratio expounded in the invention can effectively improve individual psychiatric symptoms such as the anxiety and ahedonia caused and deteriorated by the nerve inflammation and influences of actual physiological changes such as pressure level enhancement and weight loss, provides an adjuvant therapy reference which is applied in clinic in practice for neurodegeneration diseases such as dementia caused or deteriorated by melancholia or multiple kinds of nerve inflammation, and has an application prospectin preventing and treating relevant diseases.

The invention relates to a healthcare pillow for preventing and curing alopecia areata. A pillow inner of the healthcare pillow is made of the following raw materials by weight: 40-50g of Chinese angelica, 40-50g of danshen root, 30-40g of dodder seed, 40-50g of magnolia flower, 40-50g of tuber fleece-flower stem, 30-40g of large-head atractylodes rhizome, 40-50g of red ginseng, 40-50g of unprocessed rehmannia root, 40-50g of ophiopogon root, 30-40g of garter snake, 30-40g of acanthopanax root bark, 30-40g of Chinese taxillus herb and 40-50g of double-teeth pubescent angelica root. By using herbaceous plants as raw materials, the effects of promoting hair follicles growth, strengthening hair roots and nourishing and blackening hairs are achieved, patients are enabled to get far away from mental symptoms such as anxiety, worry, sadness, mental strain and emotional lability, the sleeping state and the sleeping quality are kept good to guarantee normal living state and daily behaviors, and the goals of improving head blood circulation, strengthening hair roots and relieving hair loss are achieved.

The invention relates to the technical field of traditional Chinese medicines, and specifically discloses a traditional Chinese medicine composition for alleviating extrapyramidal side effectsof antipsychotics and application thereof. The traditional Chinese medicine composition is prepared from the following crude drugs in parts by weight: 6-12 parts of rhizoma gastrodiae, 9-15 parts of ramulus uncariae cum uncis, 9-15 parts of raw concha haliotidis, 6-12 parts of fructus gardeniae, 9-15 parts of radix cyathulae, 6-12 parts of cortex eucommiae, 9-15 parts of radix rehmanniae preparata and 6-12 parts of cortex moutan. Clinical tests prove that the traditional Chinese medicine composition disclosed by the invention in combination with aripiprazole has an effect of alleviating mental symptoms and extrapyramidal side effects of a patient, and the effect is equivalent to that of a combination of the aripiprazole and artane; and drug side effects are fewer. The application of the traditional Chinese medicine composition disclosed by the invention can improve drug use safety and effectiveness of the antipsychotics, and has a relatively good application prospect.

The invention relates to a method for treating partial androgen deficiency of middle and old aged men by using sporoderm-broken ganoderma spores. Patients undergo medical history inquiry and PADAM self scoring, arterial blood is extracted on an empty stomach in morning to determine the content of testosterone (T), erythrocyte superoxide dismutase (SOD) and malondialdehyde (MDA), 600mg of sporoderm-broken ganoderma spore capsules (Yingkanghuo, researched and monitored by Food Engineering Research Center of the Ministry for National Education in China) are uniformly taken three times every day, a treatment course comprises 3 weeks, and other mental symptom treatment medicines are no longer taken in the spore taking period.

The invention relates to a composition of an oral solid medicine having good vivo behaviors. The composition of the solid medicine has unit dosage forms and is measured with a releasing rate measuring method, and the release amounts of each unit dosage form are 15%-45%, 40%-80% and more than 80% of the labelled amount when the time period reaches one hour, four hours or eight hours respectively. The composition of the oral solid medicine can be applied to cerebrovascular diseases, improves brain metabolism and psychiatric symptoms, activates the respiratory activity of brain mitochondria, and improves brain energy metabolism of cerebral ischemia and the utilization rate of glucose inside the brain, so that the production of triphosadenine inside the brain is increased, the brain mitochondria are prevented from producing lipid peroxidase, and the membrane barrier caused by lipid peroxidation of a brain mitochondrial membrane and brain function damages caused by chronic cerebrovascular diseases, cerebral traumas and the like are prevented; and mental and behavioral disorders such as subjective symptoms, language barriers, dysphoria, depression, hypomnesia, mental decline and the like are improved.

The invention discloses a eurycoma longifolia compound biological preparation and a preparation method thereof. The eurycoma longifolia compound biological preparation is prepared from eurycoma longifolia superfine concentrated solution colla corii asini, radix angelica sinensis, common yam rhizomes, Chinese chive seeds, herba epimedii, fructus lycii, liquorice roots, ursine seal testes and penis, oysters, corn cervi pantotrichum, penis cervi, human placenta and the like through a scientific preparation process. According to the specific symptoms, physical symptoms and mental symptoms of male sexual dysfunction, the male sexual dysfunction is treated wholly, comprehensively and harmoniously by starting from the organism system, and the advantages of being remarkable in clinical curative effect and small in toxic and side effect, treating both symptoms and root causes and the like are achieved.

The invention relates to the technical field of traditional Chinese medicines, and discloses a traditional Chinese medicine formula for mainly treating mental diseases such as depression, the traditional Chinese medicine formula comprises the following components: radix bupleuri, fossil fragments, scutellaria baicalensis, ginger, ochre, ginseng, cassia twig, poria cocos, rhizoma pinellinae praeparata, prepared rhubarb, oyster, JIANQU and Chinese date; the traditional Chinese medicine formula disclosed by the invention is a pure traditional Chinese medicine preparation, has a good curative effect on depression mental symptoms appearing for a long time, is mainly characterized in that the depression symptoms gradually disappear and the like, has no side effect compared with western medicines, can be stopped after treatment, and does not need to be taken all the time.

A drug containing a compound having the formula (I):

or a pharmacologically acceptable salt thereof or their hydrates, which alleviates motor complications associated with a treatment with levodopa for Parkinson's disease, delays the onset of motor complications associated with a treatment with levodopa, and inhibiting or delaying the advance of symptoms of Parkinson's disease is provided. The compound having the formula (I) has a serotonin 1A receptor partial agonist action, does not have an antagonist action against dopamine D2 receptors, has an agonist action against dopamine D3 receptors, has an effect of alleviation and delay of onset of motor complications associated with repeated doses of levodopa and, further, is also effective against associated with psychiatric symptoms in advanced stage Parkinson's disease patients.